Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Conway

Showing results (71-80 of 146) with videos related to

Pageof 15
Sort By:
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy programHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2010
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportJason Grebely, Elizabeth Knight, Krista A Genoway, et al.
HIV Clinical Trials|October 27, 2010
Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad® efficacy and safety (SMiLES)José A Vazquez, Lauren L Patton, Joel B Epstein, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug usersJason Grebely, Jesse D Raffa, Caite Meagher, et al.
Drug and Alcohol Dependence|November 13, 2007
Barriers associated with the treatment of hepatitis C virus infection among illicit drug usersJason Grebely, Krista A Genoway, Jesse D Raffa, et al.
Canadian Liver Journal|August 22, 2022
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysisMatt Driedger, Marie-Louise Vachon, Alexander Wong, et al.
Journal of Viral Hepatitis|August 13, 2024
Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC AnalysisHaris Imsirovic, Gisela Macphail, Brian Conway, et al.
BMC Public Health|September 5, 2020
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrantsCurtis L Cooper, Daniel Read, Marie-Louise Vachon, et al.
Journal of Virology|January 19, 2002
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infectionBluma G Brenner, Jean-Pierre Routy, Marco Petrella, et al.
Pageof 15

Showing results (71-80 of 146) with videos related to

Sort By:
Pageof 15
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy programHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2010
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportJason Grebely, Elizabeth Knight, Krista A Genoway, et al.
HIV Clinical Trials|October 27, 2010
Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole Lauriad® efficacy and safety (SMiLES)José A Vazquez, Lauren L Patton, Joel B Epstein, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug usersJason Grebely, Jesse D Raffa, Caite Meagher, et al.
Drug and Alcohol Dependence|November 13, 2007
Barriers associated with the treatment of hepatitis C virus infection among illicit drug usersJason Grebely, Krista A Genoway, Jesse D Raffa, et al.
Canadian Liver Journal|August 22, 2022
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysisMatt Driedger, Marie-Louise Vachon, Alexander Wong, et al.
Journal of Viral Hepatitis|August 13, 2024
Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC AnalysisHaris Imsirovic, Gisela Macphail, Brian Conway, et al.
BMC Public Health|September 5, 2020
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrantsCurtis L Cooper, Daniel Read, Marie-Louise Vachon, et al.
Journal of Virology|January 19, 2002
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infectionBluma G Brenner, Jean-Pierre Routy, Marco Petrella, et al.
Pageof 15